Influence of bone conduction transducer type and placement on ocular and cervical vestibular evoked myogenic potentials.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 04 2021
19 04 2021
Historique:
received:
27
11
2020
accepted:
25
03
2021
entrez:
20
4
2021
pubmed:
21
4
2021
medline:
9
11
2021
Statut:
epublish
Résumé
Evaluating the effectiveness of different bone conduction (BC) transducers with controlled coupling force to elicit cervical and ocular vestibular evoked myogenic potentials (cVEMPs, oVEMPs) in healthy subjects by comparing response rates, amplitudes, latencies, thresholds and asymmetry ratios. Prospective experimental study including healthy participants. VEMPs were measured to different stimulation modes; the BC transducer coupling force was controlled to 5.4 (± 0.5) Newton. cVEMPs: to bone conducted vibration (BCV) with the B81 transducer on the mastoid; oVEMPs: to BCV with the B81 on the mastoid, BCV with the B81 on the forehead, and BCV with the Mini-Shaker 4810 on the forehead. Air conducted sound (ACS) with insert earphones was used as reference. Data of 24 normal subjects (mean age 25.3 (± 3.0) years) were analyzed. ACS and BCV with the B81on the mastoid evoked cVEMPs in 100% of ears. The highest oVEMP response rates were obtained with the B81 on the mastoid (83-92%), the lowest with the B81 on the forehead (17-22%). The Mini-Shaker elicited lower response rates (65%) compared to results from the literature without coupling force control and compared to ACS (78-87%). Amplitudes were higher for BCV than ACS. ACS and BCV on the mastoid caused higher asymmetry compared to BCV forehead stimulation. The B81 was feasible to elicit VEMPs with mastoid placement and can be used as an approved medical device to measure BCV VEMPs in a clinical set-up. Normative asymmetry values have to be established due to higher variability for mastoid stimulation.
Identifiants
pubmed: 33875696
doi: 10.1038/s41598-021-87682-1
pii: 10.1038/s41598-021-87682-1
pmc: PMC8055867
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8500Références
Otol Neurotol. 2010 Jan;31(1):157-61
pubmed: 19887977
Hear Res. 2016 Jan;331:131-43
pubmed: 26626360
Ear Hear. 2010 Apr;31(2):283-8
pubmed: 19812500
Clin Neurophysiol. 2005 Aug;116(8):1938-48
pubmed: 15979939
Audiol Neurootol. 2014;19(5):327-35
pubmed: 25358828
Acta Otolaryngol. 2020 May;140(5):366-372
pubmed: 32022613
Acta Otolaryngol. 2008 Jun;128(6):639-43
pubmed: 18568497
Exp Brain Res. 2011 Jun;211(2):251-63
pubmed: 21512797
Int J Audiol. 2015 May;54(5):334-40
pubmed: 25519145
Clin Neurophysiol. 2008 Sep;119(9):2135-47
pubmed: 18639490
Clin Neurophysiol. 2010 Feb;121(2):132-44
pubmed: 19897412
Clin Neurophysiol. 2011 Nov;122(11):2282-9
pubmed: 21550301
J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):190-7
pubmed: 8126503
Neurology. 2007 Apr 10;68(15):1227-9
pubmed: 17420408
Clin Neurophysiol. 2007 Feb;118(2):381-90
pubmed: 17141563
Otol Neurotol. 2012 Oct;33(8):1368-74
pubmed: 22975905
Neurosci Lett. 2008 Oct 17;444(1):36-41
pubmed: 18706484
Exp Brain Res. 2011 May;210(3-4):347-52
pubmed: 21113779
J Neurophysiol. 2018 Mar 1;119(3):1045-1056
pubmed: 29357475
Exp Brain Res. 2014 Apr;232(4):1073-84
pubmed: 24463425
Curr Neurol Neurosci Rep. 2015 May;15(5):22
pubmed: 25773001
PLoS One. 2017 Mar 22;12(3):e0174184
pubmed: 28328999
J Appl Physiol (1985). 2009 Sep;107(3):841-52
pubmed: 19574507
Clin Neurophysiol. 2014 Mar;125(3):615-20
pubmed: 24076134
Med Devices (Auckl). 2018 Sep 06;11:301-312
pubmed: 30233258
Clin Exp Pharmacol Physiol. 2014 May;41(5):371-80
pubmed: 24754528
Clin Neurophysiol Pract. 2019 Feb 26;4:47-68
pubmed: 30949613